Zobrazeno 1 - 10
of 21
pro vyhledávání: '"E. E. Fedotova"'
Publikováno v:
Известия ТИНРО, Vol 202, Iss 1, Pp 225-233 (2022)
Brown algae can be used as raw materials for pharmacological and functional extracts, in particular carotenoids of brown alga Sargassum pallidum are a source for biologically active substances, as a carotenoid fucoxanthin with a wide spectrum of prop
Externí odkaz:
https://doaj.org/article/21c0071e7eba4238a8f5eff77fd466cc
Autor:
M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 6, Pp 816-824 (2022)
Aim. To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial fibrillation (AF) and chronic heart failure (CHF) based on prospective registries of patients wi
Externí odkaz:
https://doaj.org/article/68fb3be770f04a7eb88568b915ba2712
Autor:
M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 702-711 (2021)
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials
Externí odkaz:
https://doaj.org/article/e9b6d3b313304148a6caa15308d1e5d5
Autor:
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 888-898 (2020)
Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom como
Externí odkaz:
https://doaj.org/article/cfdcd982a2af41b792e5349981d3ba70
Publikováno v:
Известия ТИНРО, Vol 200, Iss 4, Pp 1008-1015 (2020)
Fucoxanthin is a widespread carotenoid contained in tissues of brown algae, known by its antitumor activity and ability to suppress cancer cells growth. Its inclusion into diet prevents accumulation of the body fat and regulates level of glucose and
Externí odkaz:
https://doaj.org/article/252ee00cec21473a9c14c815bd193086
Autor:
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 4, Pp 538-545 (2019)
Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF we
Externí odkaz:
https://doaj.org/article/cffb8f5bb8cf4bad9b3036b762be4b08
Autor:
M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 4, Pp 495-505 (2017)
Aim. To determine the proportion of patients with atrial fibrillation (AF) among hospitalized patients in the departments of the multidisciplinary hospital and to study the structure of the associated cardiovascular diseases (CVD) and drug therapy wi
Externí odkaz:
https://doaj.org/article/abaa75e882724378989b77cc6f551dd3
Autor:
S. Yu. Martsevich, E. V. Kudryashov, M. M. Loukianov, T. A. Gomova, Е. Yu. Okshina, V. V. Yakusevich, V. G. Klyashtorny, V. P. Mikhin, A. V. Zagrebelny, Oxana Drapkina, E. N. Belova, E. Yu. Andrenko, A. N. Makoveeva, K. G. Pereverzeva, M. M. Valiakhmetov, Sergey Boytsov, Ju. E. Tatsii, S. S. Yakushin, A. N. Vorobiev, Yu. V. Maslennikova, E. M. Pozdnyakova, E. E. Fedotova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 5, Pp 702-711 (2021)
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials
Autor:
V. P. Mikhin, A. N. Vorobyev, Yu. V. Maslennikova, E. V. Kudryashov, E. E. Fedotova, Sergey Boytsov, V. V. Yakusevich, Oxana Drapkina, E. Yu. Andreenko, Ju. E. Tatsii, S. S. Yakushin, V. G. Klyashtorny, E. M. Pozdnyakova, M. M. Loukianov, E. Yu. Okshina, S. Yu. Martsevich, T. A. Gomova, K. G. Pereverzeva, A. V. Zagrebelnyy, M. N. Valiakhmetov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 6, Pp 888-898 (2020)
Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom como
Autor:
V. V. Yakusevich, Oxana Drapkina, E. Y. Andreenko, M. A. Panagopulu, A. V. Zagrebelnyy, K. G. Pereverzeva, Sergey Boytsov, E. V. Kudryashov, E. E. Fedotova, V. P. Mikhin, E. Yu. Okshina, A. N. Vorobyev, S. Yu. Martsevich, T. A. Gomova, S. S. Yakushin, V. G. Klyashtorny, M. N. Valiakhmetov, E. M. Pozdnyakova, M. M. Loukianov, Yu. V. Maslennikova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 15, Iss 4, Pp 538-545 (2019)
Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF we